Publication | Closed Access
Botulinum Toxin as Monotherapy in Symptomatic Trigeminal Neuralgia
18
Citations
10
References
2016
Year
BTX-A has an excellent safety profile and may be efficient for patients with symptomatic TN not suited for conventional therapies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1